I would like to categorically deny any rumors that we are the target of a class-action lawsuit from readers who claim to have suffered musculoskeletal overuse injuries from holding and transporting the heftier issues of 2004, not to mention the psychological trauma of confronting the larger amount of information that has been arriving when each issue hits their doorsteps or desktops. Nevertheless, in this era of the 20-second sound bite, we suspect that the concept of divvying up our content into 12 smaller, more easily digestible portions will appeal to our readers. Papers that just miss inclusion in one issue will only have to wait a month before they see the light of day. Readers will be able to "read early" as well as often, as AJSM Preview will continue to provide an online peek at forthcoming articles.
Other changes for 2005 appear in our structured abstracts. We are now asking our contributors to select the description of their study designs from a finite list of choices listed below. The explanations of these study designs have been distilled from a number of sources, including the Oxford Centre for Evidence-Based Medicine (CEBM). We anticipate that this change will make it easier for readers to recognize the basic methodology of each published study and compare it to others throughout the literature. Included with each study design, if appropriate, will be the "level of evidence" category assigned to that study type by the CEBM. A given study design is usually assigned a certain corresponding level of evidence, although there is some latitude depending on the details of the investigation's methodology.
The CEBM is an organization based in Oxford, England, that was founded to help physicians practice evidencebased medicine. The term evidence-based medicine refers to a method of practicing medicine, not of doing research. It calls on medical practitioners to make each decision in the course of caring for their patients based on the best available evidence in the medical literature. As part of this process, the CEBM has created a matrix listing the types of data that can be used to help in each kind of medical decision (diagnostic, prognostic, therapeutic, etc) that assigns a hierarchical "level of evidence" to each publication according to its scientific methodology. The level of evidence assignment helps the practitioner to decide how much to rely on a given publication when formulating a clinical decision. The "highest" level of evidence is usually considered to be the synthesis of a number of individual studies of high quality, whereas the "lowest" is expert opinion based on anecdotal experience. Because the process is designed specifically to assist in the promulgation of clinical decisions, only study types that are pertinent to clinical decision making are assigned a level of evidence in the CEBM matrix.
We hope that using standardized study descriptions and identifying the level of evidence in the abstracts of our articles will make it easier for readers to follow the principles of evidence-based medicine when caring for their own patients. Our new monthly publication schedule will allow them to access the evidence more often.
Bruce Reider, MD
Chicago, Illinois
AJSM STUDY TYPES

Meta-analysis:
A systematic overview of studies that pools results of 2 or more studies to obtain an overall answer to a question or interest. It summarizes quantitatively the evidence regarding a treatment, procedure, or association. Systematic Review: An article that examines published material on a clearly described subject in a systematic way. There must be a description of how the evidence on this topic was tracked down, from what sources, and with what inclusion and exclusion criteria. The AJSM will consider such articles for its "Current Concepts" section. Randomized Controlled Clinical Trial: A group of patients is randomized into an experimental group and a control group. These groups are followed up for the variables/outcomes of interest. A nonrandomized controlled clinical trial is considered either a cohort study or a case series, depending on how successfully the experimental and control groups are matched.
The American Journal of Sports Medicine
Crossover Study Design: The administration of 2 or more experimental therapies, one after the other, in a specified or random order to the same group of patients. Cohort Study: Involves identification of 2 groups (cohorts) of patients, one group that receives the exposure of interest and another group that does not, and following these cohorts forward for the outcome of interest. Case Control Study: A study that involves identifying patients who have the outcome of interest (eg, cases of lung cancer) and patients without the same outcome (controls), and looking back to see if they had the exposure of interest (eg, cigarette smoking).
Cross-sectional Study:
The observation of a defined population at a single point in time or time interval. Exposure and outcome are determined simultaneously. Case Series: Describes characteristics of a group of patients with a particular condition or who have under-gone a particular treatment. No control group is used in the study, although the discussion may compare the results to others published in the literature. Case Report: Similar to the case series, except that only one or a small group of cases is reported. Controlled Laboratory Study: An in vitro or in vivo investigation in which one group receiving an experimental treatment is compared to one or more groups receiving no treatment or an alternate treatment. Descriptive Laboratory Study: An in vivo or in vitro study that describes characteristics such as the anatomy, physiology, or kinesiology of a broad range of specimens or subjects or of a specific group of interest.
The level of evidence of a study type may vary with the methodological details of the study.
